The researchers in the Science Translational Medicine paper, working directly with Illumina, first developed a diagnostic test that captured 600 genes that were likely to be the reason the babies wound up in the NICU. That panel is being sold as a kit by Illumina and will likely be used by some commercial laboratories that have government certifications to do diagnostic testing.